Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-23.24%
↓ 108% below average
Average (30q)
276.69%
Historical baseline
Range
High:9013.19%
Low:-200.00%
Volatility
3329.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -23.24% |
| Q2 2025 | 33.93% |
| Q1 2025 | 15.41% |
| Q4 2024 | -16.55% |
| Q3 2024 | -102.21% |
| Q2 2024 | 9013.19% |
| Q1 2024 | 16.76% |
| Q4 2023 | -57.27% |
| Q3 2023 | -1.85% |
| Q2 2023 | 3.57% |
| Q1 2023 | -17.89% |
| Q4 2022 | 8.65% |
| Q3 2022 | -7.22% |
| Q2 2022 | -12.79% |
| Q1 2022 | -56.36% |
| Q4 2021 | -1.85% |
| Q3 2021 | 1.82% |
| Q2 2021 | -7.84% |
| Q1 2021 | -8.51% |
| Q4 2020 | 38.96% |
| Q3 2020 | -54.00% |
| Q2 2020 | 28.57% |
| Q1 2020 | -22.81% |
| Q4 2019 | 18.57% |
| Q3 2019 | -79.49% |
| Q2 2019 | -200.00% |
| Q1 2019 | 18.75% |
| Q4 2018 | 0.00% |
| Q2 2018 | 21.88% |
| Q1 2018 | 27.27% |
| Q4 2017 | 0.00% |